Home › Funds › Rock Springs Capital Management LP › TARS

Rock Springs Capital Management LP position in TARS

TARSUS PHARMACEUTICALS INC · Health Care

Rock Springs Capital Management LP reported holding 285,122 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$22.4M, representing 1.21% of its reported portfolio and ranking #20 among its reported holdings. Rock Springs Capital Management LP has disclosed TARS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)285.12K sh
Reported value held$22.41M
Portfolio Weight1.21%
First reportedQ4 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's TARS position evolved

Rock Springs Capital Management LP first disclosed a stake in TARS in Q4 2024 at 110,889 shares (US$6.1M). The position peaked in Q3 2026 at 285,122 shares, worth US$22.4M. Across 8 filings, Rock Springs Capital Management LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 285,122 shares valued at US$22.4M — an increase of 8,035 shares quarter over quarter.. Notable position changes include a 220% increase in Q1 2025 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 110.89K $6.14M New
Q1 2025 354.38K $18.20M Add
Q2 2025 373.75K $15.14M Add
Q3 2025 288.34K $17.14M Reduce
Q4 2025 260.34K $21.32M Reduce
Q1 2026 225.18K $15.80M Reduce
Q2 2026 277.09K $17.44M Add
Q3 2026 285.12K $22.41M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TARS and 13F data

TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$299.3M), RTW INVESTMENTS, LP (US$273.9M), Paradigm Biocapital Advisors LP (US$180.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARS

All TARS fund holders →

FAQ

How long has Rock Springs Capital Management LP held TARS?

Rock Springs Capital Management LP has disclosed TARS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Rock Springs Capital Management LP's current position in TARS?

As of Q3 2026, Rock Springs Capital Management LP holds 285.12K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $22.41M, representing 1.21% of its reported portfolio and ranking #20.

Has Rock Springs Capital Management LP been buying or selling TARS?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in TARS. The position peaked in Q3 2026 at 285.12K shares.

Which other funds hold TARS?

Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.